Contera raises USD 29 million from South Korean investors, expands in Denmark
![After a fresh capital injection, Contera keeps moving toward its goal of being listed in South Korea. | Foto: Bioinnovation Institute / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12308616.ece/ALTERNATES/schema-16_9/doc7bn16mbh12rakcmy8dw.jpg)
Contera Pharma has just received fresh financing for its plans to go public on South Korean stock exchange KOSDAQ.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.